Global Antibody-drug Conjugates Market Research Report 2024, Forecast to 2032
Report Overview
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
The global Antibody-drug Conjugates market size was estimated at USD 2831.30 million in 2023 and is projected to reach USD 4280.61 million by 2032, exhibiting a CAGR of 4.70% during the forecast period.
North America Antibody-drug Conjugates market size was estimated at USD 798.40 million in 2023, at a CAGR of 4.03% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Antibody-drug Conjugates market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antibody-drug Conjugates Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antibody-drug Conjugates market in any manner.
Global Antibody-drug Conjugates Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ImmunoGen
Seattle Genetics
Roche
Takeda
Market Segmentation (by Type)
Adcetris
Kadcyla
Market Segmentation (by Application)
Breast Cancer
Lymphoma
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibody-drug Conjugates Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antibody-drug Conjugates, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
The global Antibody-drug Conjugates market size was estimated at USD 2831.30 million in 2023 and is projected to reach USD 4280.61 million by 2032, exhibiting a CAGR of 4.70% during the forecast period.
North America Antibody-drug Conjugates market size was estimated at USD 798.40 million in 2023, at a CAGR of 4.03% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Antibody-drug Conjugates market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antibody-drug Conjugates Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antibody-drug Conjugates market in any manner.
Global Antibody-drug Conjugates Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ImmunoGen
Seattle Genetics
Roche
Takeda
Market Segmentation (by Type)
Adcetris
Kadcyla
Market Segmentation (by Application)
Breast Cancer
Lymphoma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antibody-drug Conjugates Market
- Overview of the regional outlook of the Antibody-drug Conjugates Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibody-drug Conjugates Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antibody-drug Conjugates, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antibody-drug Conjugates
1.2 Key Market Segments
1.2.1 Antibody-drug Conjugates Segment by Type
1.2.2 Antibody-drug Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIBODY-DRUG CONJUGATES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antibody-drug Conjugates Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Antibody-drug Conjugates Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIBODY-DRUG CONJUGATES MARKET COMPETITIVE LANDSCAPE
3.1 Global Antibody-drug Conjugates Sales by Manufacturers (2019-2024)
3.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2019-2024)
3.3 Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antibody-drug Conjugates Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antibody-drug Conjugates Sales Sites, Area Served, Product Type
3.6 Antibody-drug Conjugates Market Competitive Situation and Trends
3.6.1 Antibody-drug Conjugates Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antibody-drug Conjugates Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTIBODY-DRUG CONJUGATES INDUSTRY CHAIN ANALYSIS
4.1 Antibody-drug Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIBODY-DRUG CONJUGATES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTIBODY-DRUG CONJUGATES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody-drug Conjugates Sales Market Share by Type (2019-2024)
6.3 Global Antibody-drug Conjugates Market Size Market Share by Type (2019-2024)
6.4 Global Antibody-drug Conjugates Price by Type (2019-2024)
7 ANTIBODY-DRUG CONJUGATES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody-drug Conjugates Market Sales by Application (2019-2024)
7.3 Global Antibody-drug Conjugates Market Size (M USD) by Application (2019-2024)
7.4 Global Antibody-drug Conjugates Sales Growth Rate by Application (2019-2024)
8 ANTIBODY-DRUG CONJUGATES MARKET CONSUMPTION BY REGION
8.1 Global Antibody-drug Conjugates Sales by Region
8.1.1 Global Antibody-drug Conjugates Sales by Region
8.1.2 Global Antibody-drug Conjugates Sales Market Share by Region
8.2 North America
8.2.1 North America Antibody-drug Conjugates Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antibody-drug Conjugates Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antibody-drug Conjugates Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antibody-drug Conjugates Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antibody-drug Conjugates Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTIBODY-DRUG CONJUGATES MARKET PRODUCTION BY REGION
9.1 Global Production of Antibody-drug Conjugates by Region (2019-2024)
9.2 Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2024)
9.3 Global Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Antibody-drug Conjugates Production
9.4.1 North America Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.4.2 North America Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Antibody-drug Conjugates Production
9.5.1 Europe Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.5.2 Europe Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Antibody-drug Conjugates Production (2019-2024)
9.6.1 Japan Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.6.2 Japan Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Antibody-drug Conjugates Production (2019-2024)
9.7.1 China Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.7.2 China Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 ImmunoGen
10.1.1 ImmunoGen Antibody-drug Conjugates Basic Information
10.1.2 ImmunoGen Antibody-drug Conjugates Product Overview
10.1.3 ImmunoGen Antibody-drug Conjugates Product Market Performance
10.1.4 ImmunoGen Business Overview
10.1.5 ImmunoGen Antibody-drug Conjugates SWOT Analysis
10.1.6 ImmunoGen Recent Developments
10.2 Seattle Genetics
10.2.1 Seattle Genetics Antibody-drug Conjugates Basic Information
10.2.2 Seattle Genetics Antibody-drug Conjugates Product Overview
10.2.3 Seattle Genetics Antibody-drug Conjugates Product Market Performance
10.2.4 Seattle Genetics Business Overview
10.2.5 Seattle Genetics Antibody-drug Conjugates SWOT Analysis
10.2.6 Seattle Genetics Recent Developments
10.3 Roche
10.3.1 Roche Antibody-drug Conjugates Basic Information
10.3.2 Roche Antibody-drug Conjugates Product Overview
10.3.3 Roche Antibody-drug Conjugates Product Market Performance
10.3.4 Roche Antibody-drug Conjugates SWOT Analysis
10.3.5 Roche Business Overview
10.3.6 Roche Recent Developments
10.4 Takeda
10.4.1 Takeda Antibody-drug Conjugates Basic Information
10.4.2 Takeda Antibody-drug Conjugates Product Overview
10.4.3 Takeda Antibody-drug Conjugates Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
11 ANTIBODY-DRUG CONJUGATES MARKET FORECAST BY REGION
11.1 Global Antibody-drug Conjugates Market Size Forecast
11.2 Global Antibody-drug Conjugates Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antibody-drug Conjugates Market Size Forecast by Country
11.2.3 Asia Pacific Antibody-drug Conjugates Market Size Forecast by Region
11.2.4 South America Antibody-drug Conjugates Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Antibody-drug Conjugates by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Antibody-drug Conjugates Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Antibody-drug Conjugates by Type (2025-2032)
12.1.2 Global Antibody-drug Conjugates Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Antibody-drug Conjugates by Type (2025-2032)
12.2 Global Antibody-drug Conjugates Market Forecast by Application (2025-2032)
12.2.1 Global Antibody-drug Conjugates Sales (K MT) Forecast by Application
12.2.2 Global Antibody-drug Conjugates Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antibody-drug Conjugates
1.2 Key Market Segments
1.2.1 Antibody-drug Conjugates Segment by Type
1.2.2 Antibody-drug Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIBODY-DRUG CONJUGATES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antibody-drug Conjugates Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Antibody-drug Conjugates Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIBODY-DRUG CONJUGATES MARKET COMPETITIVE LANDSCAPE
3.1 Global Antibody-drug Conjugates Sales by Manufacturers (2019-2024)
3.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2019-2024)
3.3 Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antibody-drug Conjugates Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antibody-drug Conjugates Sales Sites, Area Served, Product Type
3.6 Antibody-drug Conjugates Market Competitive Situation and Trends
3.6.1 Antibody-drug Conjugates Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antibody-drug Conjugates Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTIBODY-DRUG CONJUGATES INDUSTRY CHAIN ANALYSIS
4.1 Antibody-drug Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIBODY-DRUG CONJUGATES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTIBODY-DRUG CONJUGATES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody-drug Conjugates Sales Market Share by Type (2019-2024)
6.3 Global Antibody-drug Conjugates Market Size Market Share by Type (2019-2024)
6.4 Global Antibody-drug Conjugates Price by Type (2019-2024)
7 ANTIBODY-DRUG CONJUGATES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody-drug Conjugates Market Sales by Application (2019-2024)
7.3 Global Antibody-drug Conjugates Market Size (M USD) by Application (2019-2024)
7.4 Global Antibody-drug Conjugates Sales Growth Rate by Application (2019-2024)
8 ANTIBODY-DRUG CONJUGATES MARKET CONSUMPTION BY REGION
8.1 Global Antibody-drug Conjugates Sales by Region
8.1.1 Global Antibody-drug Conjugates Sales by Region
8.1.2 Global Antibody-drug Conjugates Sales Market Share by Region
8.2 North America
8.2.1 North America Antibody-drug Conjugates Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antibody-drug Conjugates Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antibody-drug Conjugates Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antibody-drug Conjugates Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antibody-drug Conjugates Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTIBODY-DRUG CONJUGATES MARKET PRODUCTION BY REGION
9.1 Global Production of Antibody-drug Conjugates by Region (2019-2024)
9.2 Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2024)
9.3 Global Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Antibody-drug Conjugates Production
9.4.1 North America Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.4.2 North America Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Antibody-drug Conjugates Production
9.5.1 Europe Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.5.2 Europe Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Antibody-drug Conjugates Production (2019-2024)
9.6.1 Japan Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.6.2 Japan Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Antibody-drug Conjugates Production (2019-2024)
9.7.1 China Antibody-drug Conjugates Production Growth Rate (2019-2024)
9.7.2 China Antibody-drug Conjugates Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 ImmunoGen
10.1.1 ImmunoGen Antibody-drug Conjugates Basic Information
10.1.2 ImmunoGen Antibody-drug Conjugates Product Overview
10.1.3 ImmunoGen Antibody-drug Conjugates Product Market Performance
10.1.4 ImmunoGen Business Overview
10.1.5 ImmunoGen Antibody-drug Conjugates SWOT Analysis
10.1.6 ImmunoGen Recent Developments
10.2 Seattle Genetics
10.2.1 Seattle Genetics Antibody-drug Conjugates Basic Information
10.2.2 Seattle Genetics Antibody-drug Conjugates Product Overview
10.2.3 Seattle Genetics Antibody-drug Conjugates Product Market Performance
10.2.4 Seattle Genetics Business Overview
10.2.5 Seattle Genetics Antibody-drug Conjugates SWOT Analysis
10.2.6 Seattle Genetics Recent Developments
10.3 Roche
10.3.1 Roche Antibody-drug Conjugates Basic Information
10.3.2 Roche Antibody-drug Conjugates Product Overview
10.3.3 Roche Antibody-drug Conjugates Product Market Performance
10.3.4 Roche Antibody-drug Conjugates SWOT Analysis
10.3.5 Roche Business Overview
10.3.6 Roche Recent Developments
10.4 Takeda
10.4.1 Takeda Antibody-drug Conjugates Basic Information
10.4.2 Takeda Antibody-drug Conjugates Product Overview
10.4.3 Takeda Antibody-drug Conjugates Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
11 ANTIBODY-DRUG CONJUGATES MARKET FORECAST BY REGION
11.1 Global Antibody-drug Conjugates Market Size Forecast
11.2 Global Antibody-drug Conjugates Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antibody-drug Conjugates Market Size Forecast by Country
11.2.3 Asia Pacific Antibody-drug Conjugates Market Size Forecast by Region
11.2.4 South America Antibody-drug Conjugates Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Antibody-drug Conjugates by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Antibody-drug Conjugates Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Antibody-drug Conjugates by Type (2025-2032)
12.1.2 Global Antibody-drug Conjugates Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Antibody-drug Conjugates by Type (2025-2032)
12.2 Global Antibody-drug Conjugates Market Forecast by Application (2025-2032)
12.2.1 Global Antibody-drug Conjugates Sales (K MT) Forecast by Application
12.2.2 Global Antibody-drug Conjugates Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antibody-drug Conjugates Market Size Comparison by Region (M USD)
Table 5. Global Antibody-drug Conjugates Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antibody-drug Conjugates Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2022)
Table 10. Global Market Antibody-drug Conjugates Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antibody-drug Conjugates Sales Sites and Area Served
Table 12. Manufacturers Antibody-drug Conjugates Product Type
Table 13. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antibody-drug Conjugates
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antibody-drug Conjugates Market Challenges
Table 22. Global Antibody-drug Conjugates Sales by Type (K MT)
Table 23. Global Antibody-drug Conjugates Market Size by Type (M USD)
Table 24. Global Antibody-drug Conjugates Sales (K MT) by Type (2019-2024)
Table 25. Global Antibody-drug Conjugates Sales Market Share by Type (2019-2024)
Table 26. Global Antibody-drug Conjugates Market Size (M USD) by Type (2019-2024)
Table 27. Global Antibody-drug Conjugates Market Size Share by Type (2019-2024)
Table 28. Global Antibody-drug Conjugates Price (USD/MT) by Type (2019-2024)
Table 29. Global Antibody-drug Conjugates Sales (K MT) by Application
Table 30. Global Antibody-drug Conjugates Market Size by Application
Table 31. Global Antibody-drug Conjugates Sales by Application (2019-2024) & (K MT)
Table 32. Global Antibody-drug Conjugates Sales Market Share by Application (2019-2024)
Table 33. Global Antibody-drug Conjugates Sales by Application (2019-2024) & (M USD)
Table 34. Global Antibody-drug Conjugates Market Share by Application (2019-2024)
Table 35. Global Antibody-drug Conjugates Sales Growth Rate by Application (2019-2024)
Table 36. Global Antibody-drug Conjugates Sales by Region (2019-2024) & (K MT)
Table 37. Global Antibody-drug Conjugates Sales Market Share by Region (2019-2024)
Table 38. North America Antibody-drug Conjugates Sales by Country (2019-2024) & (K MT)
Table 39. Europe Antibody-drug Conjugates Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Antibody-drug Conjugates Sales by Region (2019-2024) & (K MT)
Table 41. South America Antibody-drug Conjugates Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Antibody-drug Conjugates Sales by Region (2019-2024) & (K MT)
Table 43. Global Antibody-drug Conjugates Production (K MT) by Region (2019-2024)
Table 44. Global Antibody-drug Conjugates Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2024)
Table 46. Global Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. ImmunoGen Antibody-drug Conjugates Basic Information
Table 52. ImmunoGen Antibody-drug Conjugates Product Overview
Table 53. ImmunoGen Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. ImmunoGen Business Overview
Table 55. ImmunoGen Antibody-drug Conjugates SWOT Analysis
Table 56. ImmunoGen Recent Developments
Table 57. Seattle Genetics Antibody-drug Conjugates Basic Information
Table 58. Seattle Genetics Antibody-drug Conjugates Product Overview
Table 59. Seattle Genetics Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Seattle Genetics Business Overview
Table 61. Seattle Genetics Antibody-drug Conjugates SWOT Analysis
Table 62. Seattle Genetics Recent Developments
Table 63. Roche Antibody-drug Conjugates Basic Information
Table 64. Roche Antibody-drug Conjugates Product Overview
Table 65. Roche Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Roche Antibody-drug Conjugates SWOT Analysis
Table 67. Roche Business Overview
Table 68. Roche Recent Developments
Table 69. Takeda Antibody-drug Conjugates Basic Information
Table 70. Takeda Antibody-drug Conjugates Product Overview
Table 71. Takeda Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Takeda Business Overview
Table 73. Takeda Recent Developments
Table 74. Global Antibody-drug Conjugates Sales Forecast by Region (2025-2032) & (K MT)
Table 75. Global Antibody-drug Conjugates Market Size Forecast by Region (2025-2032) & (M USD)
Table 76. North America Antibody-drug Conjugates Sales Forecast by Country (2025-2032) & (K MT)
Table 77. North America Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 78. Europe Antibody-drug Conjugates Sales Forecast by Country (2025-2032) & (K MT)
Table 79. Europe Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 80. Asia Pacific Antibody-drug Conjugates Sales Forecast by Region (2025-2032) & (K MT)
Table 81. Asia Pacific Antibody-drug Conjugates Market Size Forecast by Region (2025-2032) & (M USD)
Table 82. South America Antibody-drug Conjugates Sales Forecast by Country (2025-2032) & (K MT)
Table 83. South America Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 84. Middle East and Africa Antibody-drug Conjugates Consumption Forecast by Country (2025-2032) & (Units)
Table 85. Middle East and Africa Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 86. Global Antibody-drug Conjugates Sales Forecast by Type (2025-2032) & (K MT)
Table 87. Global Antibody-drug Conjugates Market Size Forecast by Type (2025-2032) & (M USD)
Table 88. Global Antibody-drug Conjugates Price Forecast by Type (2025-2032) & (USD/MT)
Table 89. Global Antibody-drug Conjugates Sales (K MT) Forecast by Application (2025-2032)
Table 90. Global Antibody-drug Conjugates Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antibody-drug Conjugates Market Size Comparison by Region (M USD)
Table 5. Global Antibody-drug Conjugates Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antibody-drug Conjugates Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2022)
Table 10. Global Market Antibody-drug Conjugates Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antibody-drug Conjugates Sales Sites and Area Served
Table 12. Manufacturers Antibody-drug Conjugates Product Type
Table 13. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antibody-drug Conjugates
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antibody-drug Conjugates Market Challenges
Table 22. Global Antibody-drug Conjugates Sales by Type (K MT)
Table 23. Global Antibody-drug Conjugates Market Size by Type (M USD)
Table 24. Global Antibody-drug Conjugates Sales (K MT) by Type (2019-2024)
Table 25. Global Antibody-drug Conjugates Sales Market Share by Type (2019-2024)
Table 26. Global Antibody-drug Conjugates Market Size (M USD) by Type (2019-2024)
Table 27. Global Antibody-drug Conjugates Market Size Share by Type (2019-2024)
Table 28. Global Antibody-drug Conjugates Price (USD/MT) by Type (2019-2024)
Table 29. Global Antibody-drug Conjugates Sales (K MT) by Application
Table 30. Global Antibody-drug Conjugates Market Size by Application
Table 31. Global Antibody-drug Conjugates Sales by Application (2019-2024) & (K MT)
Table 32. Global Antibody-drug Conjugates Sales Market Share by Application (2019-2024)
Table 33. Global Antibody-drug Conjugates Sales by Application (2019-2024) & (M USD)
Table 34. Global Antibody-drug Conjugates Market Share by Application (2019-2024)
Table 35. Global Antibody-drug Conjugates Sales Growth Rate by Application (2019-2024)
Table 36. Global Antibody-drug Conjugates Sales by Region (2019-2024) & (K MT)
Table 37. Global Antibody-drug Conjugates Sales Market Share by Region (2019-2024)
Table 38. North America Antibody-drug Conjugates Sales by Country (2019-2024) & (K MT)
Table 39. Europe Antibody-drug Conjugates Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Antibody-drug Conjugates Sales by Region (2019-2024) & (K MT)
Table 41. South America Antibody-drug Conjugates Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Antibody-drug Conjugates Sales by Region (2019-2024) & (K MT)
Table 43. Global Antibody-drug Conjugates Production (K MT) by Region (2019-2024)
Table 44. Global Antibody-drug Conjugates Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2024)
Table 46. Global Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Antibody-drug Conjugates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. ImmunoGen Antibody-drug Conjugates Basic Information
Table 52. ImmunoGen Antibody-drug Conjugates Product Overview
Table 53. ImmunoGen Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. ImmunoGen Business Overview
Table 55. ImmunoGen Antibody-drug Conjugates SWOT Analysis
Table 56. ImmunoGen Recent Developments
Table 57. Seattle Genetics Antibody-drug Conjugates Basic Information
Table 58. Seattle Genetics Antibody-drug Conjugates Product Overview
Table 59. Seattle Genetics Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Seattle Genetics Business Overview
Table 61. Seattle Genetics Antibody-drug Conjugates SWOT Analysis
Table 62. Seattle Genetics Recent Developments
Table 63. Roche Antibody-drug Conjugates Basic Information
Table 64. Roche Antibody-drug Conjugates Product Overview
Table 65. Roche Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Roche Antibody-drug Conjugates SWOT Analysis
Table 67. Roche Business Overview
Table 68. Roche Recent Developments
Table 69. Takeda Antibody-drug Conjugates Basic Information
Table 70. Takeda Antibody-drug Conjugates Product Overview
Table 71. Takeda Antibody-drug Conjugates Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Takeda Business Overview
Table 73. Takeda Recent Developments
Table 74. Global Antibody-drug Conjugates Sales Forecast by Region (2025-2032) & (K MT)
Table 75. Global Antibody-drug Conjugates Market Size Forecast by Region (2025-2032) & (M USD)
Table 76. North America Antibody-drug Conjugates Sales Forecast by Country (2025-2032) & (K MT)
Table 77. North America Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 78. Europe Antibody-drug Conjugates Sales Forecast by Country (2025-2032) & (K MT)
Table 79. Europe Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 80. Asia Pacific Antibody-drug Conjugates Sales Forecast by Region (2025-2032) & (K MT)
Table 81. Asia Pacific Antibody-drug Conjugates Market Size Forecast by Region (2025-2032) & (M USD)
Table 82. South America Antibody-drug Conjugates Sales Forecast by Country (2025-2032) & (K MT)
Table 83. South America Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 84. Middle East and Africa Antibody-drug Conjugates Consumption Forecast by Country (2025-2032) & (Units)
Table 85. Middle East and Africa Antibody-drug Conjugates Market Size Forecast by Country (2025-2032) & (M USD)
Table 86. Global Antibody-drug Conjugates Sales Forecast by Type (2025-2032) & (K MT)
Table 87. Global Antibody-drug Conjugates Market Size Forecast by Type (2025-2032) & (M USD)
Table 88. Global Antibody-drug Conjugates Price Forecast by Type (2025-2032) & (USD/MT)
Table 89. Global Antibody-drug Conjugates Sales (K MT) Forecast by Application (2025-2032)
Table 90. Global Antibody-drug Conjugates Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antibody-drug Conjugates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antibody-drug Conjugates Market Size (M USD), 2019-2032
Figure 5. Global Antibody-drug Conjugates Market Size (M USD) (2019-2032)
Figure 6. Global Antibody-drug Conjugates Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antibody-drug Conjugates Market Size by Country (M USD)
Figure 11. Antibody-drug Conjugates Sales Share by Manufacturers in 2023
Figure 12. Global Antibody-drug Conjugates Revenue Share by Manufacturers in 2023
Figure 13. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antibody-drug Conjugates Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antibody-drug Conjugates Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antibody-drug Conjugates Market Share by Type
Figure 18. Sales Market Share of Antibody-drug Conjugates by Type (2019-2024)
Figure 19. Sales Market Share of Antibody-drug Conjugates by Type in 2023
Figure 20. Market Size Share of Antibody-drug Conjugates by Type (2019-2024)
Figure 21. Market Size Market Share of Antibody-drug Conjugates by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antibody-drug Conjugates Market Share by Application
Figure 24. Global Antibody-drug Conjugates Sales Market Share by Application (2019-2024)
Figure 25. Global Antibody-drug Conjugates Sales Market Share by Application in 2023
Figure 26. Global Antibody-drug Conjugates Market Share by Application (2019-2024)
Figure 27. Global Antibody-drug Conjugates Market Share by Application in 2023
Figure 28. Global Antibody-drug Conjugates Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antibody-drug Conjugates Sales Market Share by Region (2019-2024)
Figure 30. North America Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Antibody-drug Conjugates Sales Market Share by Country in 2023
Figure 32. U.S. Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Antibody-drug Conjugates Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Antibody-drug Conjugates Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Antibody-drug Conjugates Sales Market Share by Country in 2023
Figure 37. Germany Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Antibody-drug Conjugates Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Antibody-drug Conjugates Sales Market Share by Region in 2023
Figure 44. China Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Antibody-drug Conjugates Sales and Growth Rate (K MT)
Figure 50. South America Antibody-drug Conjugates Sales Market Share by Country in 2023
Figure 51. Brazil Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Antibody-drug Conjugates Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Antibody-drug Conjugates Production Market Share by Region (2019-2024)
Figure 62. North America Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 65. China Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Antibody-drug Conjugates Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Antibody-drug Conjugates Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Antibody-drug Conjugates Market Share Forecast by Type (2025-2032)
Figure 70. Global Antibody-drug Conjugates Sales Forecast by Application (2025-2032)
Figure 71. Global Antibody-drug Conjugates Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Antibody-drug Conjugates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antibody-drug Conjugates Market Size (M USD), 2019-2032
Figure 5. Global Antibody-drug Conjugates Market Size (M USD) (2019-2032)
Figure 6. Global Antibody-drug Conjugates Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antibody-drug Conjugates Market Size by Country (M USD)
Figure 11. Antibody-drug Conjugates Sales Share by Manufacturers in 2023
Figure 12. Global Antibody-drug Conjugates Revenue Share by Manufacturers in 2023
Figure 13. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antibody-drug Conjugates Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antibody-drug Conjugates Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antibody-drug Conjugates Market Share by Type
Figure 18. Sales Market Share of Antibody-drug Conjugates by Type (2019-2024)
Figure 19. Sales Market Share of Antibody-drug Conjugates by Type in 2023
Figure 20. Market Size Share of Antibody-drug Conjugates by Type (2019-2024)
Figure 21. Market Size Market Share of Antibody-drug Conjugates by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antibody-drug Conjugates Market Share by Application
Figure 24. Global Antibody-drug Conjugates Sales Market Share by Application (2019-2024)
Figure 25. Global Antibody-drug Conjugates Sales Market Share by Application in 2023
Figure 26. Global Antibody-drug Conjugates Market Share by Application (2019-2024)
Figure 27. Global Antibody-drug Conjugates Market Share by Application in 2023
Figure 28. Global Antibody-drug Conjugates Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antibody-drug Conjugates Sales Market Share by Region (2019-2024)
Figure 30. North America Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Antibody-drug Conjugates Sales Market Share by Country in 2023
Figure 32. U.S. Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Antibody-drug Conjugates Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Antibody-drug Conjugates Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Antibody-drug Conjugates Sales Market Share by Country in 2023
Figure 37. Germany Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Antibody-drug Conjugates Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Antibody-drug Conjugates Sales Market Share by Region in 2023
Figure 44. China Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Antibody-drug Conjugates Sales and Growth Rate (K MT)
Figure 50. South America Antibody-drug Conjugates Sales Market Share by Country in 2023
Figure 51. Brazil Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Antibody-drug Conjugates Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Antibody-drug Conjugates Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Antibody-drug Conjugates Production Market Share by Region (2019-2024)
Figure 62. North America Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 65. China Antibody-drug Conjugates Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Antibody-drug Conjugates Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Antibody-drug Conjugates Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Antibody-drug Conjugates Market Share Forecast by Type (2025-2032)
Figure 70. Global Antibody-drug Conjugates Sales Forecast by Application (2025-2032)
Figure 71. Global Antibody-drug Conjugates Market Share Forecast by Application (2025-2032)
